These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22998756)

  • 1. Clinical regression of squamous cell carcinoma and keratoacanthomas in a patient treated with a hypomethylating agent.
    Randhawa J; Wong S; Atallah E; Olasz E
    Int J Dermatol; 2014 Jan; 53(1):e13-4. PubMed ID: 22998756
    [No Abstract]   [Full Text] [Related]  

  • 2. Eruptive keratoacanthoma and squamous cell carcinoma complicating imiquimod therapy: response to oral acitretin.
    Foxton G; Delaney T
    Australas J Dermatol; 2011 Feb; 52(1):66-9. PubMed ID: 21332698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple cutaneous squamous cell carcinomas during immunosuppressive therapy.
    Westburg SP; Stone OJ
    Arch Dermatol; 1973 Jun; 107(6):893-5. PubMed ID: 4575948
    [No Abstract]   [Full Text] [Related]  

  • 4. Generalized skin reactions in patients with MDS and CMML treated with azacitidine: Effective management with concomitant prednisolone.
    Almeida AM; Pierdomenico F
    Leuk Res; 2012 Sep; 36(9):e211-3. PubMed ID: 22622173
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple eruptive keratoacanthomas associated with myelodysplastic syndrome.
    Behzad M; Michl C; Pfützner W
    J Dtsch Dermatol Ges; 2012 May; 10(5):359-60. PubMed ID: 22525151
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple keratoacanthomas in a patient with myelodysplastic syndrome.
    Zhu P; Wang Y
    Lancet Haematol; 2021 Jan; 8(1):e94. PubMed ID: 33357488
    [No Abstract]   [Full Text] [Related]  

  • 7. Atypical presentations of Sweet's syndrome in patients with MDS/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitors.
    Alencar C; Abramowtiz M; Parekh S; Braunshweig I; Jacobson M; Silverman L; Verma A
    Am J Hematol; 2009 Oct; 84(10):688-9. PubMed ID: 19722261
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral isotretinoin therapy. Use in a patient with multiple cutaneous squamous cell carcinomas and keratoacanthomas.
    Levine N; Miller RC; Meyskens FL
    Arch Dermatol; 1984 Sep; 120(9):1215-7. PubMed ID: 6591861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The euphoria of hypomethylating agents in MDS and AML: is it justified?
    Sekeres MA
    Best Pract Res Clin Haematol; 2013 Sep; 26(3):275-8. PubMed ID: 24309530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient and fully reversible leukocytosis in a myelodysplastic syndrome patient upon initiation of azacitidine treatment.
    Feldmann G; Brossart P; von Lilienfeld-Toal M
    Ann Hematol; 2013 Nov; 92(11):1577-9. PubMed ID: 23584506
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypomethylating therapy and autoimmunity in MDS: an enigmatic relationship.
    Kotsianidis I; Spanoudakis E; Nakou E; Miltiades P; Margaritis D; Tsatalas C; Tzouvelekis A; Oikonomou A
    Leuk Res; 2012 Apr; 36(4):e90-2. PubMed ID: 22230300
    [No Abstract]   [Full Text] [Related]  

  • 12. Pyoderma gangrenosum secondary to azacitidine in myelodysplastic syndrome.
    Tseng E; Alhusayen R; Sade S; Buckstein R; Prica A
    Br J Haematol; 2015 May; 169(4):461. PubMed ID: 25765235
    [No Abstract]   [Full Text] [Related]  

  • 13. [Warts and epidermoid carcinoma after renal transplantation].
    Euvrard S; Chardonnet Y; Hermier C; Viac J; Thivolet J
    Ann Dermatol Venereol; 1989; 116(3):201-11. PubMed ID: 2545155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?
    Itzykson R; Thépot S; Beyne-Rauzy O; Ame S; Isnard F; Dreyfus F; Salanoubat C; Taksin AL; Chelgoum Y; Berthon C; Malfuson JV; Legros L; Vey N; Turlure P; Gardin C; Boehrer S; Ades L; Fenaux P;
    Leuk Res; 2012 Apr; 36(4):397-400. PubMed ID: 22177456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe exacerbation of multiple self-healing squamous epithelioma (Ferguson-Smith disease) with radiotherapy, which was successfully treated with acitretin.
    Robertson SJ; Bashir SJ; Pichert G; Robson A; Whittaker S
    Clin Exp Dermatol; 2010 Jun; 35(4):e100-2. PubMed ID: 19874360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Topical cytostatic treatment of epitheliomas with a 5 per cent 5-fluorouracil ointment].
    Ebner H
    Z Haut Geschlechtskr; 1968 Sep; 43(18):757-62. PubMed ID: 5715906
    [No Abstract]   [Full Text] [Related]  

  • 17. Caution using hypomethylating agents in myelodysplasia or myeloid leukemia with complex cytogenetics.
    Turturro F; Leary C; Stephens J; Veillon D; Lowery-Nordberg M
    J Clin Oncol; 2010 Aug; 28(22):e380-1. PubMed ID: 20458054
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia.
    Voso MT; Breccia M; Lunghi M; Poloni A; Niscola P; Finelli C; Bari A; Musto P; Zambello R; Fianchi L; Alimena G; Leone G
    Eur J Haematol; 2013 Apr; 90(4):345-8. PubMed ID: 23336938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atraumatic splenic rupture in patients with myelodysplastic syndromes: report of a case occurred during treatment with 5-azacitidine and review of the literature.
    Forghieri F; Morselli M; Leonardi G; Potenza L; Bonacorsi G; Coluccio V; Paolini A; Maccaferri M; Colaci E; Fantuzzi V; Bigliardi S; Zaldini P; Riva G; Barozzi P; Leonardi L; Rossi A; Marasca R; Narni F; Luppi M
    Leuk Res; 2012 Mar; 36(3):e52-6. PubMed ID: 22172466
    [No Abstract]   [Full Text] [Related]  

  • 20. Differentiating Keratoacanthoma From Squamous Cell Carcinoma: Are We Losing the Battle or Our Bearings? - Comment on "Intralesional Methotrexate for Keratoacanthomas: A Case Series".
    López Sanz P; Fernández-Parrado M; Escario Travesedo E
    Actas Dermosifiliogr; 2024 Mar; 115(3):328-329. PubMed ID: 37716500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.